| NCT05864144 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1, PHASE2 | 2023-05-31 | 2027-06 | 2027-06 |
| NCT04217720 | SNS-301 Monotherapy in High Risk MDS and CMML | WITHDRAWN | PHASE2 | 2020-04-01 | 2023-01-01 | 2022-01-01 |
| NCT04034225 | Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN | TERMINATED | PHASE1, PHASE2 | 2019-11-11 | 2021-06-28 | 2021-06-28 |
| NCT03120832 | Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients | COMPLETED | PHASE1 | 2016-12 | 2018-12 | 2018-12 |